- Home
- PDD vs BSX Comparison
PDD vs BSX Comparison
Compare PDD & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDD
- BSX
- Stock Information
- Founded
- PDD 2015
- BSX 1979
- Country
- PDD Ireland
- BSX United States
- Employees
- PDD N/A
- BSX N/A
- Industry
- PDD Business Services
- BSX Medical/Dental Instruments
- Sector
- PDD Consumer Discretionary
- BSX Health Care
- Exchange
- PDD Nasdaq
- BSX Nasdaq
- Market Cap
- PDD 173.5B
- BSX 157.6B
- IPO Year
- PDD 2018
- BSX 1992
- Fundamental
- Price
- PDD $120.22
- BSX $105.55
- Analyst Decision
- PDD Buy
- BSX Strong Buy
- Analyst Count
- PDD 11
- BSX 22
- Target Price
- PDD $131.73
- BSX $118.32
- AVG Volume (30 Days)
- PDD 9.1M
- BSX 5.9M
- Earning Date
- PDD 08-25-2025
- BSX 10-22-2025
- Dividend Yield
- PDD N/A
- BSX N/A
- EPS Growth
- PDD N/A
- BSX 36.90
- EPS
- PDD 9.23
- BSX 1.68
- Revenue
- PDD $57,179,362,067.00
- BSX $18,494,000,000.00
- Revenue This Year
- PDD $9.93
- BSX $19.75
- Revenue Next Year
- PDD $15.62
- BSX $10.98
- P/E Ratio
- PDD $13.03
- BSX $62.79
- Revenue Growth
- PDD 19.91
- BSX 21.44
- 52 Week Low
- PDD $87.11
- BSX $79.53
- 52 Week High
- PDD $155.67
- BSX $108.94
- Technical
- Relative Strength Index (RSI)
- PDD 54.99
- BSX 53.71
- Support Level
- PDD $120.01
- BSX $104.80
- Resistance Level
- PDD $133.33
- BSX $107.01
- Average True Range (ATR)
- PDD 4.32
- BSX 1.53
- MACD
- PDD -0.03
- BSX 0.18
- Stochastic Oscillator
- PDD 35.80
- BSX 72.91
About PDD PDD Holdings Inc.
PDD Holdings operates commerce businesses in over 80 countries globally. Its main operations are Pinduoduo, a social commerce platform in China, and Temu, a global e-commerce marketplace. PDD also has a community group purchase business in China. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.